Comparison of Sedation Anesthesia between Midazolam and Midazolam/Alfentanil: for Prolotherapy and Intramuscular Stimulation
Dae Hyun Jo, Sang Jin Kim, Hyungsuk Lee, Myoung‐Hee Kim
Abstract
Open-access reader
Dae Hyun Jo, Sang Jin Kim, Hyungsuk Lee, Myoung‐Hee Kim
Abstract
Open-access reader
Background: The presence of pain during interventional pain management such as prolotherapy and intramuscular stimulation is stressful to patients and can affect the treatment outcome.We studied the safety and efficacy of two drug regimens: midazolam alone and midazolam/alfentanil for sedation anesthesia during prolotherapy and intramuscular stimulation.Methods: Fifty three patients received either midazolam 0.04-0.08mg/kg (Group M) or midazolam 0.01-0.02mg/kg with alfentanil 4-8μg/kg (Group A) for prolotherapy or intramuscular stimulation.We recorded the pain response, sedation score and side effects during the procedure, as well as amnesia, satisfaction and time to discharge after the procedure.Results: Both drug regimens had significant sedation scores, amnesia and overall provided patient satisfaction.The treatment of pain was superior in Group A. Respiratory depression of three patients occurred in Group A. The time to discharge was longer in Group M.Conclusions: Midazolam and midazolam/alfentanil used for sedation anesthesia during prolotherapy and intramuscular stimulation were both effective; however, midazolam alone was the safer approach.(Korean J Anesthesiol 2007; 52: 306∼9)
OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Background: The presence of pain during interventional pain management such as prolotherapy and intramuscular stimulation is stressful to patients and can affect the treatment outcome.We studied the safety and efficacy of two drug regimens: midazolam alone and midazolam/alfentanil for sedation anesthesia during prolotherapy and intramuscular stimulation.Methods: Fifty three patients received either midazolam 0.04-0.08mg/kg (Group M) or midazolam 0.01-0.02mg/kg with alfentanil 4-8μg/kg (Group A) for prolotherapy or intramuscular stimulation.We recorded the pain response, sedation score and side effects during the procedure, as well as amnesia, satisfaction and time to discharge after the procedure.Results: Both drug regimens had significant sedation scores, amnesia and overall provided patient satisfaction.The treatment of pain was superior in Group A. Respiratory depression of three patients occurred in Group A. The time to discharge was longer in Group M.Conclusions: Midazolam and midazolam/alfentanil used for sedation anesthesia during prolotherapy and intramuscular stimulation were both effective; however, midazolam alone was the safer approach.(Korean J Anesthesiol 2007; 52: 306∼9)
Key concepts: Alfentanil, Midazolam, Anesthesia, Medicine, Sedation, Prolotherapy, Fentanyl, Alternative medicine